nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—ADRA2A—Brimonidine—glaucoma	0.0789	0.115	CbGbCtD
Nefazodone—ADRA2A—Apraclonidine—glaucoma	0.0789	0.115	CbGbCtD
Nefazodone—ADRA1A—Apraclonidine—glaucoma	0.0756	0.11	CbGbCtD
Nefazodone—ADRA2A—Dipivefrin—glaucoma	0.063	0.0916	CbGbCtD
Nefazodone—ADRA1A—Dipivefrin—glaucoma	0.0604	0.0878	CbGbCtD
Nefazodone—ADRA1B—Clonidine—glaucoma	0.0398	0.0578	CbGbCtD
Nefazodone—SLC6A2—Clonidine—glaucoma	0.0363	0.0528	CbGbCtD
Nefazodone—ADRA2A—Clonidine—glaucoma	0.0327	0.0476	CbGbCtD
Nefazodone—ADRA1A—Clonidine—glaucoma	0.0314	0.0456	CbGbCtD
Nefazodone—CYP2D6—Carteolol—glaucoma	0.0294	0.0427	CbGbCtD
Nefazodone—CYP2D6—Betaxolol—glaucoma	0.0199	0.0289	CbGbCtD
Nefazodone—CYP3A5—Clonidine—glaucoma	0.0178	0.0258	CbGbCtD
Nefazodone—CYP2D6—Methazolamide—glaucoma	0.0151	0.0219	CbGbCtD
Nefazodone—CYP3A4—Pilocarpine—glaucoma	0.0142	0.0206	CbGbCtD
Nefazodone—ABCB1—Timolol—glaucoma	0.0136	0.0197	CbGbCtD
Nefazodone—CYP2D6—Timolol—glaucoma	0.0128	0.0186	CbGbCtD
Nefazodone—ABCB1—Clonidine—glaucoma	0.0116	0.0168	CbGbCtD
Nefazodone—CYP3A4—Brinzolamide—glaucoma	0.0111	0.0162	CbGbCtD
Nefazodone—CYP2D6—Clonidine—glaucoma	0.0109	0.0158	CbGbCtD
Nefazodone—CYP3A4—Dorzolamide—glaucoma	0.0107	0.0156	CbGbCtD
Nefazodone—CYP3A4—Methazolamide—glaucoma	0.00958	0.0139	CbGbCtD
Nefazodone—CYP3A4—Acetazolamide—glaucoma	0.00766	0.0111	CbGbCtD
Nefazodone—CYP3A4—Clonidine—glaucoma	0.00693	0.0101	CbGbCtD
Nefazodone—Body temperature increased—Acetazolamide—glaucoma	0.000136	0.000508	CcSEcCtD
Nefazodone—Tinnitus—Betaxolol—glaucoma	0.000136	0.000508	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000136	0.000507	CcSEcCtD
Nefazodone—Flushing—Betaxolol—glaucoma	0.000135	0.000505	CcSEcCtD
Nefazodone—Ill-defined disorder—Clonidine—glaucoma	0.000135	0.000505	CcSEcCtD
Nefazodone—Pain—Dorzolamide—glaucoma	0.000135	0.000504	CcSEcCtD
Nefazodone—Insomnia—Pilocarpine—glaucoma	0.000135	0.000503	CcSEcCtD
Nefazodone—Decreased appetite—Brinzolamide—glaucoma	0.000135	0.000503	CcSEcCtD
Nefazodone—Weight decreased—Timolol—glaucoma	0.000134	0.000503	CcSEcCtD
Nefazodone—Pain—Travoprost—glaucoma	0.000134	0.000502	CcSEcCtD
Nefazodone—Constipation—Travoprost—glaucoma	0.000134	0.000502	CcSEcCtD
Nefazodone—Agitation—Clonidine—glaucoma	0.000134	0.0005	CcSEcCtD
Nefazodone—Paraesthesia—Pilocarpine—glaucoma	0.000134	0.0005	CcSEcCtD
Nefazodone—Asthenia—Bimatoprost—glaucoma	0.000134	0.0005	CcSEcCtD
Nefazodone—Angioedema—Clonidine—glaucoma	0.000133	0.000498	CcSEcCtD
Nefazodone—Dyspnoea—Pilocarpine—glaucoma	0.000133	0.000496	CcSEcCtD
Nefazodone—Pain—Brinzolamide—glaucoma	0.000132	0.000495	CcSEcCtD
Nefazodone—Somnolence—Pilocarpine—glaucoma	0.000132	0.000495	CcSEcCtD
Nefazodone—Pruritus—Bimatoprost—glaucoma	0.000132	0.000493	CcSEcCtD
Nefazodone—Diarrhoea—Apraclonidine—glaucoma	0.000131	0.000492	CcSEcCtD
Nefazodone—Malaise—Clonidine—glaucoma	0.000131	0.000491	CcSEcCtD
Nefazodone—Dyspepsia—Pilocarpine—glaucoma	0.000131	0.00049	CcSEcCtD
Nefazodone—Chills—Betaxolol—glaucoma	0.000131	0.000489	CcSEcCtD
Nefazodone—Syncope—Clonidine—glaucoma	0.000131	0.000488	CcSEcCtD
Nefazodone—Feeling abnormal—Dorzolamide—glaucoma	0.00013	0.000485	CcSEcCtD
Nefazodone—Decreased appetite—Pilocarpine—glaucoma	0.000129	0.000484	CcSEcCtD
Nefazodone—Feeling abnormal—Travoprost—glaucoma	0.000129	0.000483	CcSEcCtD
Nefazodone—Conjunctivitis—Timolol—glaucoma	0.000129	0.000482	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000129	0.000482	CcSEcCtD
Nefazodone—Alopecia—Betaxolol—glaucoma	0.000129	0.000481	CcSEcCtD
Nefazodone—Palpitations—Clonidine—glaucoma	0.000129	0.000481	CcSEcCtD
Nefazodone—Gastrointestinal pain—Travoprost—glaucoma	0.000128	0.00048	CcSEcCtD
Nefazodone—Loss of consciousness—Clonidine—glaucoma	0.000128	0.000479	CcSEcCtD
Nefazodone—Feeling abnormal—Brinzolamide—glaucoma	0.000128	0.000477	CcSEcCtD
Nefazodone—Pain—Pilocarpine—glaucoma	0.000127	0.000476	CcSEcCtD
Nefazodone—Constipation—Pilocarpine—glaucoma	0.000127	0.000476	CcSEcCtD
Nefazodone—Cough—Clonidine—glaucoma	0.000127	0.000475	CcSEcCtD
Nefazodone—Sweating—Timolol—glaucoma	0.000127	0.000475	CcSEcCtD
Nefazodone—Dizziness—Apraclonidine—glaucoma	0.000127	0.000475	CcSEcCtD
Nefazodone—Urticaria—Dorzolamide—glaucoma	0.000125	0.000468	CcSEcCtD
Nefazodone—Epistaxis—Timolol—glaucoma	0.000125	0.000468	CcSEcCtD
Nefazodone—Abdominal pain—Dorzolamide—glaucoma	0.000125	0.000466	CcSEcCtD
Nefazodone—Body temperature increased—Dorzolamide—glaucoma	0.000125	0.000466	CcSEcCtD
Nefazodone—Sinusitis—Timolol—glaucoma	0.000124	0.000465	CcSEcCtD
Nefazodone—Dysgeusia—Betaxolol—glaucoma	0.000124	0.000464	CcSEcCtD
Nefazodone—Arthralgia—Clonidine—glaucoma	0.000124	0.000464	CcSEcCtD
Nefazodone—Chest pain—Clonidine—glaucoma	0.000124	0.000464	CcSEcCtD
Nefazodone—Abdominal pain—Travoprost—glaucoma	0.000124	0.000464	CcSEcCtD
Nefazodone—Anxiety—Clonidine—glaucoma	0.000124	0.000462	CcSEcCtD
Nefazodone—Asthenia—Acetazolamide—glaucoma	0.000123	0.000461	CcSEcCtD
Nefazodone—Dizziness—Bimatoprost—glaucoma	0.000123	0.000461	CcSEcCtD
Nefazodone—Urticaria—Brinzolamide—glaucoma	0.000123	0.00046	CcSEcCtD
Nefazodone—Feeling abnormal—Pilocarpine—glaucoma	0.000123	0.000459	CcSEcCtD
Nefazodone—Discomfort—Clonidine—glaucoma	0.000122	0.000458	CcSEcCtD
Nefazodone—Vomiting—Apraclonidine—glaucoma	0.000122	0.000457	CcSEcCtD
Nefazodone—Muscle spasms—Betaxolol—glaucoma	0.000122	0.000456	CcSEcCtD
Nefazodone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000122	0.000455	CcSEcCtD
Nefazodone—Hypersensitivity—Brimonidine—glaucoma	0.000122	0.000454	CcSEcCtD
Nefazodone—Dry mouth—Clonidine—glaucoma	0.000121	0.000453	CcSEcCtD
Nefazodone—Bradycardia—Timolol—glaucoma	0.000121	0.000453	CcSEcCtD
Nefazodone—Dermatitis—Apraclonidine—glaucoma	0.000121	0.000453	CcSEcCtD
Nefazodone—Headache—Apraclonidine—glaucoma	0.00012	0.00045	CcSEcCtD
Nefazodone—Confusional state—Clonidine—glaucoma	0.00012	0.000448	CcSEcCtD
Nefazodone—Vision blurred—Betaxolol—glaucoma	0.000119	0.000447	CcSEcCtD
Nefazodone—Rhinitis—Timolol—glaucoma	0.000119	0.000446	CcSEcCtD
Nefazodone—Oedema—Clonidine—glaucoma	0.000119	0.000444	CcSEcCtD
Nefazodone—Tremor—Betaxolol—glaucoma	0.000119	0.000444	CcSEcCtD
Nefazodone—Hallucination—Timolol—glaucoma	0.000118	0.000443	CcSEcCtD
Nefazodone—Asthenia—Brimonidine—glaucoma	0.000118	0.000443	CcSEcCtD
Nefazodone—Infection—Clonidine—glaucoma	0.000118	0.000442	CcSEcCtD
Nefazodone—Body temperature increased—Pilocarpine—glaucoma	0.000118	0.00044	CcSEcCtD
Nefazodone—Abdominal pain—Pilocarpine—glaucoma	0.000118	0.00044	CcSEcCtD
Nefazodone—Ill-defined disorder—Betaxolol—glaucoma	0.000118	0.00044	CcSEcCtD
Nefazodone—Diarrhoea—Acetazolamide—glaucoma	0.000118	0.00044	CcSEcCtD
Nefazodone—Rash—Bimatoprost—glaucoma	0.000117	0.000439	CcSEcCtD
Nefazodone—Dermatitis—Bimatoprost—glaucoma	0.000117	0.000439	CcSEcCtD
Nefazodone—Oedema peripheral—Timolol—glaucoma	0.000117	0.000438	CcSEcCtD
Nefazodone—Anaemia—Betaxolol—glaucoma	0.000117	0.000438	CcSEcCtD
Nefazodone—Shock—Clonidine—glaucoma	0.000117	0.000437	CcSEcCtD
Nefazodone—Pruritus—Brimonidine—glaucoma	0.000117	0.000436	CcSEcCtD
Nefazodone—Headache—Bimatoprost—glaucoma	0.000117	0.000436	CcSEcCtD
Nefazodone—Thrombocytopenia—Clonidine—glaucoma	0.000116	0.000435	CcSEcCtD
Nefazodone—Hypersensitivity—Dorzolamide—glaucoma	0.000116	0.000434	CcSEcCtD
Nefazodone—Tachycardia—Clonidine—glaucoma	0.000116	0.000434	CcSEcCtD
Nefazodone—Hypersensitivity—Travoprost—glaucoma	0.000116	0.000432	CcSEcCtD
Nefazodone—Hyperhidrosis—Clonidine—glaucoma	0.000115	0.00043	CcSEcCtD
Nefazodone—Visual impairment—Timolol—glaucoma	0.000115	0.000429	CcSEcCtD
Nefazodone—Malaise—Betaxolol—glaucoma	0.000114	0.000428	CcSEcCtD
Nefazodone—Nausea—Apraclonidine—glaucoma	0.000114	0.000427	CcSEcCtD
Nefazodone—Hypersensitivity—Brinzolamide—glaucoma	0.000114	0.000427	CcSEcCtD
Nefazodone—Vertigo—Betaxolol—glaucoma	0.000114	0.000426	CcSEcCtD
Nefazodone—Syncope—Betaxolol—glaucoma	0.000114	0.000425	CcSEcCtD
Nefazodone—Dizziness—Acetazolamide—glaucoma	0.000114	0.000425	CcSEcCtD
Nefazodone—Anorexia—Clonidine—glaucoma	0.000113	0.000424	CcSEcCtD
Nefazodone—Asthenia—Dorzolamide—glaucoma	0.000113	0.000423	CcSEcCtD
Nefazodone—Asthenia—Travoprost—glaucoma	0.000113	0.000421	CcSEcCtD
Nefazodone—Palpitations—Betaxolol—glaucoma	0.000112	0.000419	CcSEcCtD
Nefazodone—Pruritus—Dorzolamide—glaucoma	0.000111	0.000417	CcSEcCtD
Nefazodone—Loss of consciousness—Betaxolol—glaucoma	0.000111	0.000417	CcSEcCtD
Nefazodone—Asthenia—Brinzolamide—glaucoma	0.000111	0.000415	CcSEcCtD
Nefazodone—Hypotension—Clonidine—glaucoma	0.000111	0.000415	CcSEcCtD
Nefazodone—Pruritus—Travoprost—glaucoma	0.000111	0.000415	CcSEcCtD
Nefazodone—Tinnitus—Timolol—glaucoma	0.000111	0.000415	CcSEcCtD
Nefazodone—Cough—Betaxolol—glaucoma	0.000111	0.000414	CcSEcCtD
Nefazodone—Nausea—Bimatoprost—glaucoma	0.000111	0.000414	CcSEcCtD
Nefazodone—Hypersensitivity—Pilocarpine—glaucoma	0.00011	0.00041	CcSEcCtD
Nefazodone—Pruritus—Brinzolamide—glaucoma	0.00011	0.00041	CcSEcCtD
Nefazodone—Vomiting—Acetazolamide—glaucoma	0.000109	0.000409	CcSEcCtD
Nefazodone—Dizziness—Brimonidine—glaucoma	0.000109	0.000408	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000108	0.000405	CcSEcCtD
Nefazodone—Chest pain—Betaxolol—glaucoma	0.000108	0.000404	CcSEcCtD
Nefazodone—Arthralgia—Betaxolol—glaucoma	0.000108	0.000404	CcSEcCtD
Nefazodone—Myalgia—Betaxolol—glaucoma	0.000108	0.000404	CcSEcCtD
Nefazodone—Diarrhoea—Dorzolamide—glaucoma	0.000108	0.000403	CcSEcCtD
Nefazodone—Headache—Acetazolamide—glaucoma	0.000108	0.000403	CcSEcCtD
Nefazodone—Anxiety—Betaxolol—glaucoma	0.000108	0.000402	CcSEcCtD
Nefazodone—Insomnia—Clonidine—glaucoma	0.000107	0.000402	CcSEcCtD
Nefazodone—Diarrhoea—Travoprost—glaucoma	0.000107	0.000401	CcSEcCtD
Nefazodone—Asthenia—Pilocarpine—glaucoma	0.000107	0.000399	CcSEcCtD
Nefazodone—Paraesthesia—Clonidine—glaucoma	0.000107	0.000399	CcSEcCtD
Nefazodone—Discomfort—Betaxolol—glaucoma	0.000107	0.000399	CcSEcCtD
Nefazodone—Dyspnoea—Clonidine—glaucoma	0.000106	0.000396	CcSEcCtD
Nefazodone—Diarrhoea—Brinzolamide—glaucoma	0.000106	0.000396	CcSEcCtD
Nefazodone—Somnolence—Clonidine—glaucoma	0.000106	0.000395	CcSEcCtD
Nefazodone—Dry mouth—Betaxolol—glaucoma	0.000106	0.000395	CcSEcCtD
Nefazodone—Pruritus—Pilocarpine—glaucoma	0.000105	0.000394	CcSEcCtD
Nefazodone—Alopecia—Timolol—glaucoma	0.000105	0.000393	CcSEcCtD
Nefazodone—Confusional state—Betaxolol—glaucoma	0.000104	0.00039	CcSEcCtD
Nefazodone—Dizziness—Dorzolamide—glaucoma	0.000104	0.00039	CcSEcCtD
Nefazodone—Rash—Brimonidine—glaucoma	0.000104	0.000389	CcSEcCtD
Nefazodone—Dermatitis—Brimonidine—glaucoma	0.000104	0.000389	CcSEcCtD
Nefazodone—Dizziness—Travoprost—glaucoma	0.000104	0.000388	CcSEcCtD
Nefazodone—Oedema—Betaxolol—glaucoma	0.000103	0.000387	CcSEcCtD
Nefazodone—Headache—Brimonidine—glaucoma	0.000103	0.000386	CcSEcCtD
Nefazodone—Decreased appetite—Clonidine—glaucoma	0.000103	0.000386	CcSEcCtD
Nefazodone—Infection—Betaxolol—glaucoma	0.000103	0.000384	CcSEcCtD
Nefazodone—Dizziness—Brinzolamide—glaucoma	0.000102	0.000383	CcSEcCtD
Nefazodone—Nausea—Acetazolamide—glaucoma	0.000102	0.000382	CcSEcCtD
Nefazodone—Diarrhoea—Pilocarpine—glaucoma	0.000102	0.000381	CcSEcCtD
Nefazodone—Shock—Betaxolol—glaucoma	0.000102	0.000381	CcSEcCtD
Nefazodone—Pain—Clonidine—glaucoma	0.000102	0.00038	CcSEcCtD
Nefazodone—Constipation—Clonidine—glaucoma	0.000102	0.00038	CcSEcCtD
Nefazodone—Dysgeusia—Timolol—glaucoma	0.000101	0.000379	CcSEcCtD
Nefazodone—Thrombocytopenia—Betaxolol—glaucoma	0.000101	0.000379	CcSEcCtD
Nefazodone—Tachycardia—Betaxolol—glaucoma	0.000101	0.000378	CcSEcCtD
Nefazodone—Vomiting—Dorzolamide—glaucoma	0.0001	0.000375	CcSEcCtD
Nefazodone—Hyperhidrosis—Betaxolol—glaucoma	0.0001	0.000374	CcSEcCtD
Nefazodone—Rash—Dorzolamide—glaucoma	9.93e-05	0.000371	CcSEcCtD
Nefazodone—Dermatitis—Dorzolamide—glaucoma	9.92e-05	0.000371	CcSEcCtD
Nefazodone—Rash—Travoprost—glaucoma	9.89e-05	0.00037	CcSEcCtD
Nefazodone—Dermatitis—Travoprost—glaucoma	9.88e-05	0.000369	CcSEcCtD
Nefazodone—Headache—Dorzolamide—glaucoma	9.87e-05	0.000369	CcSEcCtD
Nefazodone—Anorexia—Betaxolol—glaucoma	9.86e-05	0.000369	CcSEcCtD
Nefazodone—Vomiting—Brinzolamide—glaucoma	9.84e-05	0.000368	CcSEcCtD
Nefazodone—Dizziness—Pilocarpine—glaucoma	9.84e-05	0.000368	CcSEcCtD
Nefazodone—Headache—Travoprost—glaucoma	9.82e-05	0.000367	CcSEcCtD
Nefazodone—Nausea—Brimonidine—glaucoma	9.8e-05	0.000366	CcSEcCtD
Nefazodone—Feeling abnormal—Clonidine—glaucoma	9.79e-05	0.000366	CcSEcCtD
Nefazodone—Rash—Brinzolamide—glaucoma	9.76e-05	0.000365	CcSEcCtD
Nefazodone—Vision blurred—Timolol—glaucoma	9.76e-05	0.000365	CcSEcCtD
Nefazodone—Dermatitis—Brinzolamide—glaucoma	9.75e-05	0.000365	CcSEcCtD
Nefazodone—Gastrointestinal pain—Clonidine—glaucoma	9.72e-05	0.000363	CcSEcCtD
Nefazodone—Headache—Brinzolamide—glaucoma	9.7e-05	0.000363	CcSEcCtD
Nefazodone—Hypotension—Betaxolol—glaucoma	9.67e-05	0.000362	CcSEcCtD
Nefazodone—Angioedema—Timolol—glaucoma	9.46e-05	0.000354	CcSEcCtD
Nefazodone—Vomiting—Pilocarpine—glaucoma	9.46e-05	0.000354	CcSEcCtD
Nefazodone—Urticaria—Clonidine—glaucoma	9.44e-05	0.000353	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betaxolol—glaucoma	9.43e-05	0.000353	CcSEcCtD
Nefazodone—Abdominal pain—Clonidine—glaucoma	9.39e-05	0.000351	CcSEcCtD
Nefazodone—Body temperature increased—Clonidine—glaucoma	9.39e-05	0.000351	CcSEcCtD
Nefazodone—Rash—Pilocarpine—glaucoma	9.38e-05	0.000351	CcSEcCtD
Nefazodone—Dermatitis—Pilocarpine—glaucoma	9.37e-05	0.000351	CcSEcCtD
Nefazodone—Insomnia—Betaxolol—glaucoma	9.36e-05	0.00035	CcSEcCtD
Nefazodone—Nausea—Dorzolamide—glaucoma	9.36e-05	0.00035	CcSEcCtD
Nefazodone—Headache—Pilocarpine—glaucoma	9.32e-05	0.000349	CcSEcCtD
Nefazodone—Nausea—Travoprost—glaucoma	9.31e-05	0.000348	CcSEcCtD
Nefazodone—Vertigo—Timolol—glaucoma	9.31e-05	0.000348	CcSEcCtD
Nefazodone—Paraesthesia—Betaxolol—glaucoma	9.29e-05	0.000347	CcSEcCtD
Nefazodone—Syncope—Timolol—glaucoma	9.29e-05	0.000347	CcSEcCtD
Nefazodone—Dyspnoea—Betaxolol—glaucoma	9.22e-05	0.000345	CcSEcCtD
Nefazodone—Nausea—Brinzolamide—glaucoma	9.2e-05	0.000344	CcSEcCtD
Nefazodone—Palpitations—Timolol—glaucoma	9.15e-05	0.000342	CcSEcCtD
Nefazodone—Dyspepsia—Betaxolol—glaucoma	9.11e-05	0.000341	CcSEcCtD
Nefazodone—Loss of consciousness—Timolol—glaucoma	9.1e-05	0.00034	CcSEcCtD
Nefazodone—Cough—Timolol—glaucoma	9.04e-05	0.000338	CcSEcCtD
Nefazodone—Decreased appetite—Betaxolol—glaucoma	8.99e-05	0.000336	CcSEcCtD
Nefazodone—Hypertension—Timolol—glaucoma	8.94e-05	0.000334	CcSEcCtD
Nefazodone—Pain—Betaxolol—glaucoma	8.85e-05	0.000331	CcSEcCtD
Nefazodone—Constipation—Betaxolol—glaucoma	8.85e-05	0.000331	CcSEcCtD
Nefazodone—Nausea—Pilocarpine—glaucoma	8.84e-05	0.000331	CcSEcCtD
Nefazodone—Arthralgia—Timolol—glaucoma	8.82e-05	0.00033	CcSEcCtD
Nefazodone—Chest pain—Timolol—glaucoma	8.82e-05	0.00033	CcSEcCtD
Nefazodone—Myalgia—Timolol—glaucoma	8.82e-05	0.00033	CcSEcCtD
Nefazodone—Anxiety—Timolol—glaucoma	8.79e-05	0.000329	CcSEcCtD
Nefazodone—Hypersensitivity—Clonidine—glaucoma	8.76e-05	0.000327	CcSEcCtD
Nefazodone—Discomfort—Timolol—glaucoma	8.71e-05	0.000326	CcSEcCtD
Nefazodone—Dry mouth—Timolol—glaucoma	8.62e-05	0.000323	CcSEcCtD
Nefazodone—Asthenia—Clonidine—glaucoma	8.53e-05	0.000319	CcSEcCtD
Nefazodone—Feeling abnormal—Betaxolol—glaucoma	8.53e-05	0.000319	CcSEcCtD
Nefazodone—Confusional state—Timolol—glaucoma	8.52e-05	0.000319	CcSEcCtD
Nefazodone—Oedema—Timolol—glaucoma	8.45e-05	0.000316	CcSEcCtD
Nefazodone—Anaphylactic shock—Timolol—glaucoma	8.45e-05	0.000316	CcSEcCtD
Nefazodone—Pruritus—Clonidine—glaucoma	8.41e-05	0.000314	CcSEcCtD
Nefazodone—Infection—Timolol—glaucoma	8.4e-05	0.000314	CcSEcCtD
Nefazodone—Shock—Timolol—glaucoma	8.32e-05	0.000311	CcSEcCtD
Nefazodone—Urticaria—Betaxolol—glaucoma	8.22e-05	0.000307	CcSEcCtD
Nefazodone—Body temperature increased—Betaxolol—glaucoma	8.18e-05	0.000306	CcSEcCtD
Nefazodone—Hyperhidrosis—Timolol—glaucoma	8.17e-05	0.000306	CcSEcCtD
Nefazodone—Diarrhoea—Clonidine—glaucoma	8.13e-05	0.000304	CcSEcCtD
Nefazodone—Anorexia—Timolol—glaucoma	8.06e-05	0.000301	CcSEcCtD
Nefazodone—Hypotension—Timolol—glaucoma	7.9e-05	0.000295	CcSEcCtD
Nefazodone—Dizziness—Clonidine—glaucoma	7.86e-05	0.000294	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Timolol—glaucoma	7.7e-05	0.000288	CcSEcCtD
Nefazodone—Insomnia—Timolol—glaucoma	7.65e-05	0.000286	CcSEcCtD
Nefazodone—Hypersensitivity—Betaxolol—glaucoma	7.62e-05	0.000285	CcSEcCtD
Nefazodone—Paraesthesia—Timolol—glaucoma	7.59e-05	0.000284	CcSEcCtD
Nefazodone—Vomiting—Clonidine—glaucoma	7.56e-05	0.000283	CcSEcCtD
Nefazodone—Dyspnoea—Timolol—glaucoma	7.54e-05	0.000282	CcSEcCtD
Nefazodone—Somnolence—Timolol—glaucoma	7.51e-05	0.000281	CcSEcCtD
Nefazodone—Rash—Clonidine—glaucoma	7.49e-05	0.00028	CcSEcCtD
Nefazodone—Dermatitis—Clonidine—glaucoma	7.49e-05	0.00028	CcSEcCtD
Nefazodone—Headache—Clonidine—glaucoma	7.45e-05	0.000278	CcSEcCtD
Nefazodone—Dyspepsia—Timolol—glaucoma	7.44e-05	0.000278	CcSEcCtD
Nefazodone—Asthenia—Betaxolol—glaucoma	7.42e-05	0.000278	CcSEcCtD
Nefazodone—Decreased appetite—Timolol—glaucoma	7.35e-05	0.000275	CcSEcCtD
Nefazodone—Pruritus—Betaxolol—glaucoma	7.32e-05	0.000274	CcSEcCtD
Nefazodone—Pain—Timolol—glaucoma	7.23e-05	0.00027	CcSEcCtD
Nefazodone—Diarrhoea—Betaxolol—glaucoma	7.08e-05	0.000265	CcSEcCtD
Nefazodone—Nausea—Clonidine—glaucoma	7.06e-05	0.000264	CcSEcCtD
Nefazodone—Feeling abnormal—Timolol—glaucoma	6.97e-05	0.00026	CcSEcCtD
Nefazodone—Gastrointestinal pain—Timolol—glaucoma	6.91e-05	0.000258	CcSEcCtD
Nefazodone—Dizziness—Betaxolol—glaucoma	6.84e-05	0.000256	CcSEcCtD
Nefazodone—Urticaria—Timolol—glaucoma	6.71e-05	0.000251	CcSEcCtD
Nefazodone—Abdominal pain—Timolol—glaucoma	6.68e-05	0.00025	CcSEcCtD
Nefazodone—Body temperature increased—Timolol—glaucoma	6.68e-05	0.00025	CcSEcCtD
Nefazodone—Vomiting—Betaxolol—glaucoma	6.58e-05	0.000246	CcSEcCtD
Nefazodone—Rash—Betaxolol—glaucoma	6.52e-05	0.000244	CcSEcCtD
Nefazodone—Dermatitis—Betaxolol—glaucoma	6.52e-05	0.000244	CcSEcCtD
Nefazodone—Headache—Betaxolol—glaucoma	6.48e-05	0.000242	CcSEcCtD
Nefazodone—Hypersensitivity—Timolol—glaucoma	6.23e-05	0.000233	CcSEcCtD
Nefazodone—Nausea—Betaxolol—glaucoma	6.15e-05	0.00023	CcSEcCtD
Nefazodone—Asthenia—Timolol—glaucoma	6.06e-05	0.000227	CcSEcCtD
Nefazodone—Pruritus—Timolol—glaucoma	5.98e-05	0.000224	CcSEcCtD
Nefazodone—Diarrhoea—Timolol—glaucoma	5.78e-05	0.000216	CcSEcCtD
Nefazodone—Dizziness—Timolol—glaucoma	5.59e-05	0.000209	CcSEcCtD
Nefazodone—Vomiting—Timolol—glaucoma	5.37e-05	0.000201	CcSEcCtD
Nefazodone—Rash—Timolol—glaucoma	5.33e-05	0.000199	CcSEcCtD
Nefazodone—Dermatitis—Timolol—glaucoma	5.32e-05	0.000199	CcSEcCtD
Nefazodone—Headache—Timolol—glaucoma	5.3e-05	0.000198	CcSEcCtD
Nefazodone—Nausea—Timolol—glaucoma	5.02e-05	0.000188	CcSEcCtD
Nefazodone—ADRA1A—Signaling Pathways—HEYL—glaucoma	2.52e-05	0.000571	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—OPN4—glaucoma	2.52e-05	0.000571	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTGFR—glaucoma	2.49e-05	0.000565	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—EDN1—glaucoma	2.49e-05	0.000564	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CTSA—glaucoma	2.49e-05	0.000564	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—SMO—glaucoma	2.46e-05	0.000558	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—SOD1—glaucoma	2.45e-05	0.000556	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—SMO—glaucoma	2.45e-05	0.000556	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NARFL—glaucoma	2.44e-05	0.000554	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CA5A—glaucoma	2.44e-05	0.000554	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTGFR—glaucoma	2.44e-05	0.000553	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—C3—glaucoma	2.39e-05	0.000541	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.38e-05	0.000538	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	2.36e-05	0.000535	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CA2—glaucoma	2.35e-05	0.000532	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—SMO—glaucoma	2.35e-05	0.000532	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HEYL—glaucoma	2.34e-05	0.000531	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—C3—glaucoma	2.34e-05	0.00053	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—TXN—glaucoma	2.29e-05	0.000519	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTGFR—glaucoma	2.27e-05	0.000514	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RPTOR—glaucoma	2.26e-05	0.000512	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RPTOR—glaucoma	2.25e-05	0.000509	CbGpPWpGaD
Nefazodone—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.22e-05	0.000503	CbGpPWpGaD
Nefazodone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.19e-05	0.000497	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NCK2—glaucoma	2.19e-05	0.000496	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NCK2—glaucoma	2.18e-05	0.000493	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—C3—glaucoma	2.17e-05	0.000493	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RPTOR—glaucoma	2.15e-05	0.000488	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—SMO—glaucoma	2.13e-05	0.000482	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—SMO—glaucoma	2.08e-05	0.000472	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NCK2—glaucoma	2.08e-05	0.000472	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RPTOR—glaucoma	1.95e-05	0.000442	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CA1—glaucoma	1.94e-05	0.000439	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—SMO—glaucoma	1.94e-05	0.000439	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RPTOR—glaucoma	1.91e-05	0.000433	CbGpPWpGaD
Nefazodone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.89e-05	0.000429	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NCK2—glaucoma	1.89e-05	0.000428	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CTSA—glaucoma	1.88e-05	0.000425	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—MMP1—glaucoma	1.87e-05	0.000424	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.87e-05	0.000424	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HDAC9—glaucoma	1.86e-05	0.000422	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.85e-05	0.000419	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HDAC9—glaucoma	1.85e-05	0.000419	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CA1—glaucoma	1.83e-05	0.000414	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—TXN—glaucoma	1.81e-05	0.000409	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—CAV1—glaucoma	1.79e-05	0.000406	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—EDN1—glaucoma	1.79e-05	0.000405	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—EDN1—glaucoma	1.78e-05	0.000403	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.78e-05	0.000402	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GSTT1—glaucoma	1.77e-05	0.000402	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CA2—glaucoma	1.77e-05	0.000402	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.77e-05	0.000401	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.77e-05	0.000401	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CTSA—glaucoma	1.77e-05	0.000401	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NCK2—glaucoma	1.72e-05	0.00039	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—FN1—glaucoma	1.71e-05	0.000387	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	1.7e-05	0.000386	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CA2—glaucoma	1.67e-05	0.000378	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—TXN—glaucoma	1.65e-05	0.000375	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—EDN1—glaucoma	1.62e-05	0.000368	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—EDN1—glaucoma	1.62e-05	0.000366	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HDAC9—glaucoma	1.61e-05	0.000364	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.57e-05	0.000357	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—C3—glaucoma	1.56e-05	0.000354	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—C3—glaucoma	1.55e-05	0.000352	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—EDN1—glaucoma	1.55e-05	0.000351	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—EDN1—glaucoma	1.55e-05	0.00035	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.51e-05	0.000343	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—C3—glaucoma	1.49e-05	0.000337	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.47e-05	0.000334	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HDAC9—glaucoma	1.46e-05	0.000331	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SMO—glaucoma	1.46e-05	0.00033	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SMO—glaucoma	1.45e-05	0.000328	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—C3—glaucoma	1.42e-05	0.000322	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ABCA1—glaucoma	1.41e-05	0.00032	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CYP1B1—glaucoma	1.41e-05	0.00032	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—C3—glaucoma	1.41e-05	0.00032	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	1.41e-05	0.000319	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—EDN1—glaucoma	1.4e-05	0.000318	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GSTT1—glaucoma	1.4e-05	0.000317	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SMO—glaucoma	1.39e-05	0.000314	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—EDN1—glaucoma	1.37e-05	0.000311	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NOS3—glaucoma	1.36e-05	0.000307	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—C3—glaucoma	1.35e-05	0.000306	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—C3—glaucoma	1.35e-05	0.000306	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK2—glaucoma	1.33e-05	0.000302	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK2—glaucoma	1.32e-05	0.0003	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—C3—glaucoma	1.32e-05	0.0003	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTT1—glaucoma	1.28e-05	0.000291	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—EDN1—glaucoma	1.28e-05	0.000289	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK2—glaucoma	1.27e-05	0.000287	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.26e-05	0.000286	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SMO—glaucoma	1.26e-05	0.000285	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—TXN—glaucoma	1.25e-05	0.000283	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SMO—glaucoma	1.23e-05	0.000279	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—C3—glaucoma	1.23e-05	0.000278	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—C3—glaucoma	1.23e-05	0.000278	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—C3—glaucoma	1.2e-05	0.000272	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CA1—glaucoma	1.19e-05	0.000271	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—TXN—glaucoma	1.18e-05	0.000267	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CTSA—glaucoma	1.16e-05	0.000262	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK2—glaucoma	1.15e-05	0.000261	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SMO—glaucoma	1.14e-05	0.000259	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NGFR—glaucoma	1.14e-05	0.000259	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NGFR—glaucoma	1.14e-05	0.000258	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GSTM1—glaucoma	1.13e-05	0.000256	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.13e-05	0.000255	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—C3—glaucoma	1.12e-05	0.000253	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ABCA1—glaucoma	1.12e-05	0.000253	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CYP1B1—glaucoma	1.12e-05	0.000253	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.11e-05	0.000252	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CA2—glaucoma	1.09e-05	0.000247	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NGFR—glaucoma	1.09e-05	0.000247	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK1—glaucoma	1.09e-05	0.000246	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK1—glaucoma	1.08e-05	0.000245	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK2—glaucoma	1.05e-05	0.000237	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK1—glaucoma	1.03e-05	0.000234	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCA1—glaucoma	1.02e-05	0.000232	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP1B1—glaucoma	1.02e-05	0.000232	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CDKN2B—glaucoma	1e-05	0.000227	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MTHFR—glaucoma	9.99e-06	0.000226	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CDKN2B—glaucoma	9.95e-06	0.000226	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NGFR—glaucoma	9.87e-06	0.000224	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—VEGFA—glaucoma	9.77e-06	0.000221	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTT1—glaucoma	9.68e-06	0.000219	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NGFR—glaucoma	9.66e-06	0.000219	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EDN1—glaucoma	9.6e-06	0.000218	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EDN1—glaucoma	9.55e-06	0.000216	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	9.52e-06	0.000216	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK1—glaucoma	9.38e-06	0.000212	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—APOE—glaucoma	9.3e-06	0.000211	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CAV1—glaucoma	9.22e-06	0.000209	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK1—glaucoma	9.18e-06	0.000208	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EDN1—glaucoma	9.14e-06	0.000207	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTT1—glaucoma	9.12e-06	0.000207	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NGFR—glaucoma	8.98e-06	0.000203	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GSTM1—glaucoma	8.92e-06	0.000202	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NGF—glaucoma	8.82e-06	0.0002	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NGF—glaucoma	8.77e-06	0.000199	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDKN2B—glaucoma	8.64e-06	0.000196	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK1—glaucoma	8.53e-06	0.000193	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	8.46e-06	0.000192	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NGF—glaucoma	8.4e-06	0.00019	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—C3—glaucoma	8.38e-06	0.00019	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—C3—glaucoma	8.34e-06	0.000189	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EDN1—glaucoma	8.29e-06	0.000188	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTM1—glaucoma	8.17e-06	0.000185	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EDN1—glaucoma	8.12e-06	0.000184	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—C3—glaucoma	7.98e-06	0.000181	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—glaucoma	7.88e-06	0.000179	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	7.86e-06	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APOE—glaucoma	7.81e-06	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APOE—glaucoma	7.76e-06	0.000176	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CAV1—glaucoma	7.73e-06	0.000175	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP1B1—glaucoma	7.71e-06	0.000175	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ABCA1—glaucoma	7.71e-06	0.000175	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CAV1—glaucoma	7.69e-06	0.000174	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TXN—glaucoma	7.69e-06	0.000174	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NGF—glaucoma	7.62e-06	0.000173	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EDN1—glaucoma	7.54e-06	0.000171	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NGF—glaucoma	7.46e-06	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOE—glaucoma	7.43e-06	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TP53—glaucoma	7.38e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CAV1—glaucoma	7.36e-06	0.000167	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—FN1—glaucoma	7.36e-06	0.000167	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOE—glaucoma	7.34e-06	0.000166	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—FN1—glaucoma	7.32e-06	0.000166	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—BAD—glaucoma	7.27e-06	0.000165	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CAV1—glaucoma	7.27e-06	0.000165	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCA1—glaucoma	7.27e-06	0.000165	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP1B1—glaucoma	7.27e-06	0.000165	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—C3—glaucoma	7.24e-06	0.000164	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—BAD—glaucoma	7.24e-06	0.000164	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—glaucoma	7.22e-06	0.000164	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—C3—glaucoma	7.09e-06	0.000161	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—FN1—glaucoma	7.01e-06	0.000159	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—glaucoma	6.97e-06	0.000158	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NGF—glaucoma	6.93e-06	0.000157	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—BAD—glaucoma	6.93e-06	0.000157	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOE—glaucoma	6.74e-06	0.000153	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOE—glaucoma	6.72e-06	0.000152	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CAV1—glaucoma	6.68e-06	0.000151	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAV1—glaucoma	6.66e-06	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOE—glaucoma	6.6e-06	0.00015	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—C3—glaucoma	6.59e-06	0.000149	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CAV1—glaucoma	6.54e-06	0.000148	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—glaucoma	6.37e-06	0.000144	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FN1—glaucoma	6.36e-06	0.000144	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—BAD—glaucoma	6.28e-06	0.000142	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FN1—glaucoma	6.23e-06	0.000141	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTM1—glaucoma	6.17e-06	0.00014	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—BAD—glaucoma	6.15e-06	0.000139	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOE—glaucoma	6.13e-06	0.000139	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CAV1—glaucoma	6.08e-06	0.000138	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTT1—glaucoma	5.96e-06	0.000135	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—glaucoma	5.85e-06	0.000133	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—glaucoma	5.82e-06	0.000132	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTM1—glaucoma	5.81e-06	0.000132	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FN1—glaucoma	5.79e-06	0.000131	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—BAD—glaucoma	5.72e-06	0.00013	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—glaucoma	5.57e-06	0.000126	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—glaucoma	5.5e-06	0.000125	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—glaucoma	5.45e-06	0.000124	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—glaucoma	5.14e-06	0.000116	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOE—glaucoma	5.07e-06	0.000115	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CDKN1B—glaucoma	5.07e-06	0.000115	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—glaucoma	5.05e-06	0.000114	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CDKN1B—glaucoma	5.04e-06	0.000114	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—glaucoma	5.04e-06	0.000114	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—glaucoma	5.03e-06	0.000114	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAV1—glaucoma	5.03e-06	0.000114	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—glaucoma	4.95e-06	0.000112	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	4.82e-06	0.000109	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOE—glaucoma	4.78e-06	0.000108	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCA1—glaucoma	4.75e-06	0.000108	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP1B1—glaucoma	4.75e-06	0.000108	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAV1—glaucoma	4.74e-06	0.000107	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—glaucoma	4.69e-06	0.000106	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—glaucoma	4.67e-06	0.000106	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—glaucoma	4.61e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—glaucoma	4.6e-06	0.000104	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—glaucoma	4.47e-06	0.000101	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDKN1B—glaucoma	4.38e-06	9.92e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	4.28e-06	9.71e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—glaucoma	4.21e-06	9.55e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—glaucoma	4.19e-06	9.5e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—glaucoma	4.05e-06	9.19e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—glaucoma	4.01e-06	9.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	3.98e-06	9.02e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—glaucoma	3.97e-06	8.99e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—glaucoma	3.8e-06	8.61e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTM1—glaucoma	3.8e-06	8.61e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—glaucoma	3.69e-06	8.36e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—glaucoma	3.64e-06	8.25e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—glaucoma	3.58e-06	8.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—glaucoma	3.56e-06	8.08e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—glaucoma	3.48e-06	7.88e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—glaucoma	3.36e-06	7.61e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—glaucoma	3.31e-06	7.5e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—glaucoma	3.28e-06	7.42e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TP53—glaucoma	3.18e-06	7.21e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TP53—glaucoma	3.17e-06	7.18e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOE—glaucoma	3.13e-06	7.08e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAV1—glaucoma	3.1e-06	7.02e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TP53—glaucoma	3.03e-06	6.87e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TP53—glaucoma	2.75e-06	6.23e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TP53—glaucoma	2.69e-06	6.1e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TP53—glaucoma	2.5e-06	5.67e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—glaucoma	2.34e-06	5.31e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—glaucoma	2.14e-06	4.85e-05	CbGpPWpGaD
